-Corona 19 vaccine, other vaccines cannot be given for a certain period
The Corona 19 Vaccination Response Promotion Team (Director: Eun-kyung Jeong) announced that as of 0 o’clock on March 15, 1,074 people received an additional vaccine for Corona 19 and completed the first dose of the Corona 19 vaccine for 588,958 people. The first Korean coronavirus infectious disease (Corona 19) vaccination started on February 26 for nursing hospitals, the elderly, mental care, and rehabilitation facility residents and workers under the age of 65. As the government has completed the first vaccination for all citizens by the third quarter and aims to form a group immunity in November, expectations for a precious daily recovery are rising.
On the other hand, because the safety and efficacy data for simultaneous vaccination with other vaccines are insufficient for the COVID-19 vaccine, it is recommended to inoculate it alone. In order to avoid interfering effects between vaccination immune response and treatment, it is necessary to maintain a minimum interval of 2 weeks before and after the first dose of the COVID-19 vaccine and 2 weeks before and after the second dose.
-Tdap vaccine that can prevent tetanus, diphtheria, and whooping cough, and recommended by strengthening the targets for vaccination by the Korea Centers for Disease Control and Prevention
Pertussis, which can be prevented through the Tdap vaccine before and after the COVID-19 vaccination, is also of interest. The secondary incidence rate of whooping cough reaches 80% in the family, and cyclic outbreaks are being confirmed at 2-3 year intervals at home and abroad.
Pertussis caused by Bordetella pertussis has been known as a fatal disease for infants and toddlers. However, like the United States and the United Kingdom, where pertussis vaccine has been popularized, the rate of whooping cough among the elderly is gradually increasing in Korea. In fact, according to the Korea Centers for Disease Control and Prevention, the proportion of patients over 60 in Korea has been increasing year by year from 2018. In 2020, last year, 9.6% more patients than those under the age of 9 (25.6%) occurred in their 60s or older (35.2%), accounting for more than those under the age of 9.
As the possibility of infant and infant infection has been raised by adult whooping cough patients with reduced immunity, the Korea Centers for Disease Control and Prevention (KCDC) revised the “Adult Vaccination Guide” in 2018 and recommended by strengthening the targets for Tdap vaccination. In order to minimize the risk of whooping cough in newborns and infants, it was expanded and concreted from existing pregnant women to siblings and grandparents in families with infants.
Professor Joon Joon of the Department of Obstetrics and Gynecology at Guro Hospital of Korea University said, “In consideration of the characteristics of whooping cough disease, which is fatal to the elderly over 65 years of age, tetanus, diphtheria, and tetanus, diphtheria, if the silver generation were born before 1958, to prevent infection of newborns and infants and grandchildren with weak immunity as well as themselves. Tdap vaccination to prevent whooping cough is necessary. “In the case of elderly people 65 years of age or older who were excluded from the corona vaccination this February-March, a specialist prior to the corona vaccination with special attention to prevent secondary spread in the home. It would be better to prevent whooping cough with the Tdap vaccine through consultation with him,” he added.
Meanwhile, GSK’s Boostrix is the only Tdap vaccine licensed for use in the elderly over the age of 65 in Korea. Boostrix can be vaccinated by adolescents and adults over the age of 10, and even over the age of 65 and prevents whooping cough, as well as diphtheria and tetanus.
Copyright ⓒ Acrofan All Right Reserved.